These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15367249)

  • 1. Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer's perspective.
    Javitz HS; Swan GE; Zbikowski SM; Curry SJ; McAfee TA; Decker D; Patterson R; Jack LM
    Value Health; 2004; 7(5):535-43. PubMed ID: 15367249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective.
    Javitz HS; Swan GE; Zbikowski SM; Curry SJ; McAfee TA; Decker DL; Patterson R; Jack LM
    Am J Manag Care; 2004 Mar; 10(3):217-26. PubMed ID: 15032259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial.
    Swan GE; McAfee T; Curry SJ; Jack LM; Javitz H; Dacey S; Bergman K
    Arch Intern Med; 2003 Oct; 163(19):2337-44. PubMed ID: 14581254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
    Nielsen K; Fiore MC
    Prev Med; 2000 Mar; 30(3):209-16. PubMed ID: 10684744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
    Swan GE; Jack LM; Curry S; Chorost M; Javitz H; McAfee T; Dacey S
    Nicotine Tob Res; 2003 Dec; 5(6):911-21. PubMed ID: 14668075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
    Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N; Nikoloutsou I; Katsani G; Dima E; Fransis K; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
    Jackson KC; Nahoopii R; Said Q; Dirani R; Brixner D
    J Occup Environ Med; 2007 Apr; 49(4):453-60. PubMed ID: 17426529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
    McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
    Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varenicline and bupropion sustained-release combination therapy for smoking cessation.
    Ebbert JO; Croghan IT; Sood A; Schroeder DR; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 Mar; 11(3):234-9. PubMed ID: 19246427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in health-related quality of life with smoking cessation treatment.
    Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG
    Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation.
    Swan GE; Jack LM; Javitz HS; McAfee T; McClure JB
    CNS Drugs; 2008; 22(3):239-56. PubMed ID: 18278978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint effect of dopaminergic genes on likelihood of smoking following treatment with bupropion SR.
    Swan GE; Jack LM; Valdes AM; Ring HZ; Ton CC; Curry SJ; McAfee T
    Health Psychol; 2007 May; 26(3):361-8. PubMed ID: 17500623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of sustained-release bupropion and placebo for smoking cessation.
    Hurt RD; Sachs DP; Glover ED; Offord KP; Johnston JA; Dale LC; Khayrallah MA; Schroeder DR; Glover PN; Sullivan CR; Croghan IT; Sullivan PM
    N Engl J Med; 1997 Oct; 337(17):1195-202. PubMed ID: 9337378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic considerations in the management of smoking cessation.
    Godfrey C; Fowler G
    Drugs; 2002; 62 Suppl 2():63-70. PubMed ID: 12109937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programs.
    Halpern MT; Khan ZM; Young TL; Battista C
    Am J Health Syst Pharm; 2000 Aug; 57(15):1421-9. PubMed ID: 10938982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.